A group of neuroscientists say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases — amyotrophic lateral sclerosis, and frontotemporal dementia — and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.